| Methods | Parallel randomised controlled trial |
| Participants | SETTING: Outpatients, Zhejiang Province, Hangzhou Red Cross Hospital, China |
| WHO PARTCIPATED: n=88 (46 in the intervention group M/F 18/28, mean age 55.6 yrs; 42 in the control M/F 17/25, mean age 54.0 yrs) | |
| INCLUSION CRITERIA: IGT (WHO 1985) | |
| EXCLUSION CRITERIA: none reported | |
| CO-MORBIDITIES: none reported | |
| CO-MEDICATIONS:none reported | |
| Interventions | INTERVENTION: Jinqi Jiangtang tablet, oral, 7 tablets, 0.42g per tablet, three times per day, 30mins before meals plus lifestyle modification (diet and exercise) |
| CONTROL: lifestyle modification (diet and exercise) | |
| Outcomes | Fasting blood glucose (mmol/L), 2hr-GTT (mmol/L), fasting insulin, 2hr-insulin, triglycerides, total cholesterol, HDL, systolic blood pressure (kpa), diastolic blood pressure (kpa), normalisation of fasting blood glucose (n), incidence of diabetes (n) |
| Blood pressure measurement converted as follows: 1 mmHg = 0.133 kPa | |
| All outcomes reported at baseline, 3 months, 6 months and trial completion (12 months) | |
| Study details | DURATION OF INTERVENTION: 12 months |
| DURATION OF FOLLOW-UP: 12 months | |
| RUN-IN PERIOD: none | |
| Publication details | LANGUAGE OF PUBLICATION: Chinese |
| COMMERCIAL FUNDING: no | |
| NON-COMMERCIAL FUNDING: no | |
| PUBLICATION STATUS (PEER REVIEW JOURNAL): yes | |
| PUBLICATION STATUS (JOURNAL SUPPLEMENT): no | |
| PUBLICATION STATUS (ABSTRACT): no | |
| Stated aim of study | To observe the effect of Jingqi Jiangtang tablet on non-overweight people with impaired glucose tolerance. |
| Notes | |
Risk of bias table